Intellia Therapeutics (NTLA) Proxy filing summary

Voting matters and shareholder proposals

• Election of three class I directors to serve until the 2029 annual meeting, with nominees Muna Bhanji, Brian Goff, and Jesse Goodman recommended for election.

• Ratification of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026.

• Advisory vote to approve the compensation of named executive officers.

• Provision for transaction of any other business properly brought before the meeting or its adjournment.

Board of directors and corporate governance

• Board recommends all three director nominees for election to serve three-year terms until 2029.

Executive compensation and say-on-pay

• Shareholders are asked to approve, on a non-binding advisory basis, the compensation of named executive officers.